Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/080
  • Start year: 2021
  • Funders: ICS - Institut Català de la Salut, Julius Clinical Research B.V.

Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (WP1)

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/109
  • Start year: 2021
  • Funders: European Medicines Agency (EMA)

Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/110
  • Start year: 2021
  • Funders: Julius Clinical Research B.V.

An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU

  • Principal investigators: Felipe Villalobos Martínez, Felipe Villalobos Martínez
  • Code: 4R21/121
  • Start year: 2021
  • Funders: Teamit Institute, S.L.

Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R22/073
  • Start year: 2022
  • Funders: UMC Utrecht (University Medical Center Utrecht)